Bekeschus, S.; Freund, E.; Spadola, C.; Privat-Maldonado, A.; Hackbarth, C.; Bogaerts, A.; Schmidt, A.; Wende, K.; Weltmann, K.-D.; von Woedtke, T.;
et al. Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Cancers 2019, 11, 1237.
https://doi.org/10.3390/cancers11091237
AMA Style
Bekeschus S, Freund E, Spadola C, Privat-Maldonado A, Hackbarth C, Bogaerts A, Schmidt A, Wende K, Weltmann K-D, von Woedtke T,
et al. Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Cancers. 2019; 11(9):1237.
https://doi.org/10.3390/cancers11091237
Chicago/Turabian Style
Bekeschus, Sander, Eric Freund, Chiara Spadola, Angela Privat-Maldonado, Christine Hackbarth, Annemie Bogaerts, Anke Schmidt, Kristian Wende, Klaus-Dieter Weltmann, Thomas von Woedtke,
and et al. 2019. "Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis" Cancers 11, no. 9: 1237.
https://doi.org/10.3390/cancers11091237
APA Style
Bekeschus, S., Freund, E., Spadola, C., Privat-Maldonado, A., Hackbarth, C., Bogaerts, A., Schmidt, A., Wende, K., Weltmann, K. -D., von Woedtke, T., Heidecke, C. -D., Partecke, L. -I., & Käding, A.
(2019). Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Cancers, 11(9), 1237.
https://doi.org/10.3390/cancers11091237
